Vanda Pharmaceuticals Inc (VNDA)
Operating Income Growth
-65.72%
Quarterly · Period ending:
VNDA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-65.72%period ending
Latest reported-65.72%period ending
VNDA Quarterly Operating Income YoY % (-210.11% → -65.72%)
Year-over-year change
High-resolution chart · PNG
VNDA operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -65.7247% | |
| -12.7388% | |
| -292.5771% | |
| -184.4% | |
| -279.4895% | |
| -382.3931% | |
| -44.8971% | |
| -83.4862% | |
| -253.8891% | |
| -560.8283% | |
| -207.0146% | |
| -253.4033% | |
| -182.8373% | |
| 126.1312% | |
| -23.2399% | |
| -63.8784% | |
| -72.0188% | |
| -174.1611% | |
| -17.3668% | |
| 39.7443% | |
| 34.8708% | |
| 8,372.8% | |
| 146.3116% | |
| -28.0416% | |
| -7.3168% | |
| 94.0105% | |
| -53.6284% | |
| 72.6135% | |
| 152.875% | |
| -185.4627% | |
| 525.5814% | |
| 226.6098% | |
| 303.3784% | |
| 130.8879% | |
| -228.7462% | |
| -653.9051% | |
| 59.8246% | |
| 36.6253% | |
| 95.6087% | |
| 93.1559% | |
| 12.2572% | |
| -21.1989% | |
| -121.3694% | |
| -558.9088% | |
| 74.7385% | |
| 61.2725% | |
| 1,008.9996% | |
| 73.21% | |
| -594.9501% | |
| -529.9597% | |
| -19.275% | |
| -0.1854% | |
| 61.5461% | |
| 49.2726% | |
| -8.8016% | |
| -63.8324% | |
| -434.3688% | |
| -118,914.2857% | |
| -847.1246% | |
| -542.7527% | |
| -230.8603% | |
| -99.8861% | |
| 108.5561% | |
| 109.6152% | |
| 109.3142% | |
| 193.7461% | |
| -20.7381% | |
| 30.8905% | |
| 10.926% | |
| 67.3143% | |
| 65.2813% | |
| 52.4159% | |
| 21.0127% | |
| -19.2342% | |
| -77.7004% | |
| -83.661% | |
| 20.096% | |
| 8.6235% | |
| -75.7908% | |
| -122.4582% | |
| -299.002% | |
| -210.1148% |